Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55


Survey of Ehlers-Danlos Patients' ophthalmic surgery experiences.

Louie A, Meyerle C, Francomano C, Srikumaran D, Merali F, Doyle JJ, Bower K, Bloom L, Boland MV, Mahoney N, Daoud Y, Singman EL.

Mol Genet Genomic Med. 2020 Jan 27:e1155. doi: 10.1002/mgg3.1155. [Epub ahead of print]


Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy.

Hanumunthadu D, van Dijk EHC, Dumpala S, Rajesh B, Jabeen A, Jabeen A, Ansari M, Mehta P, Shah S, Sarvaiya C, Meyerle C, Wu L, Banker A, Boon CJ, Chhablani J.

J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):164-170. doi: 10.4103/jovr.jovr_152_17.


Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.

Iftikhar M, Mir TA, Hafiz G, Zimmer-Galler I, Scott AW, Solomon SD, Sodhi A, Wenick AS, Meyerle C, Jiramongkolchai K, Liu TYA, Arevalo JF, Singh M, Kherani S, Handa JT, Campochiaro PA.

Am J Ophthalmol. 2019 Sep;205:17-26. doi: 10.1016/j.ajo.2019.03.029. Epub 2019 Apr 4.


A Backward Glance at Chronic Central Serous Chorioretinopathy.

Meyerle C.

Ophthalmology. 2019 Apr;126(4):589-590. doi: 10.1016/j.ophtha.2018.11.012. No abstract available.


Association of Ultrawide-Field Findings in Proliferative Retinopathy With Systemic Lupus Erythematosus.

Cai CX, Liu TYA, Meyerle CB.

JAMA Ophthalmol. 2019 Jan 1;137(1):e183861. doi: 10.1001/jamaophthalmol.2018.3861. Epub 2019 Jan 10. No abstract available.


Gender variation in central serous chorioretinopathy.

Hanumunthadu D, Van Dijk EHC, Gangakhedkar S, Goud A, Cheung CMG, Cherfan D, Sarvaiya C, Banker A, Meyerle C, Boon CJ, Singh R, Wu L, Chhablani J.

Eye (Lond). 2018 Nov;32(11):1703-1709. doi: 10.1038/s41433-018-0163-7. Epub 2018 Jul 9.


Central Serous Chorioretinopathy in African Americans at Wilmer Eye Institute.

Mehta PH, Chhablani J, Wang J, Meyerle CB.

J Natl Med Assoc. 2018 Jun;110(3):297-302. doi: 10.1016/j.jnma.2017.06.012. Epub 2017 Jul 27.


Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular Degeneration.

Kherani S, Scott AW, Wenick AS, Zimmer-Galler I, Brady CJ, Sodhi A, Meyerle C, Solomon SD, Shaukat R, Channa R, Adeyemo O, Handa JT, Wang J, Campochiaro PA.

Am J Ophthalmol. 2018 May;189:86-95. doi: 10.1016/j.ajo.2018.02.015. Epub 2018 Feb 28.


Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases.

Saldanha IJ, Lindsley K, Do DV, Chuck RS, Meyerle C, Jones LS, Coleman AL, Jampel HD, Dickersin K, Virgili G.

JAMA Ophthalmol. 2017 Sep 1;135(9):933-940. doi: 10.1001/jamaophthalmol.2017.2583.


Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease.

Knickelbein JE, Jacobs-El N, Wong WT, Wiley HE, Cukras CA, Meyerle CB, Chew EY.

Ophthalmol Retina. 2017 May-Jun;1(3):181-187. doi: 10.1016/j.oret.2016.10.007.


Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular Degeneration.

Thavikulwat AT, Jacobs-El N, Kim JS, Agrón E, Hasan J, Meyerle CB, Valent D, Cukras CA, Wiley HE, Wong WT, Chew EY.

Ophthalmol Retina. 2017 Jan-Feb;1(1):34-41. doi: 10.1016/j.oret.2016.09.005.



Campochiaro PA, Hafiz G, Mir TA, Scott AW, Zimmer-Galler I, Shah SM, Wenick AS, Brady CJ, Han I, He L, Channa R, Poon D, Meyerle C, Aronow MB, Sodhi A, Handa JT, Kherani S, Han Y, Sophie R, Wang G, Qian J.

Am J Ophthalmol. 2016 Oct;170:245-246. doi: 10.1016/j.ajo.2016.07.014. Epub 2016 Aug 22. No abstract available.


Preferred practice pattern in central serous chorioretinopathy.

Mehta PH, Meyerle C, Sivaprasad S, Boon C, Chhablani J.

Br J Ophthalmol. 2017 May;101(5):587-590. doi: 10.1136/bjophthalmol-2016-309247. Epub 2016 Aug 18.


Age-related macular degeneration in patients with uveitis.

Fox AR, Chew EY, Meyerle C, Vitale S, Ferris FL, Nussenblatt RB, Sen HN.

Br J Ophthalmol. 2017 Mar;101(3):342-347. doi: 10.1136/bjophthalmol-2016-308587. Epub 2016 May 6.


Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial.

Campochiaro PA, Hafiz G, Mir TA, Scott AW, Zimmer-Galler I, Shah SM, Wenick AS, Brady CJ, Han I, He L, Channa R, Poon D, Meyerle C, Aronow MB, Sodhi A, Handa JT, Kherani S, Han Y, Sophie R, Wang G, Qian J.

Am J Ophthalmol. 2016 Aug;168:13-23. doi: 10.1016/j.ajo.2016.04.017. Epub 2016 Apr 27.


A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.

Wiley HE, Thompson DJ, Bailey C, Chew EY, Cukras CA, Jaffe GJ, Lee RW, Loken EK, Meyerle CB, Wong W, Ferris FL 3rd.

Ophthalmology. 2016 Apr;123(4):841-9. doi: 10.1016/j.ophtha.2015.11.021. Epub 2016 Feb 10.


Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion.

Mir TA, Kherani S, Hafiz G, Scott AW, Zimmer-Galler I, Wenick AS, Solomon S, Han I, Poon D, He L, Shah SM, Brady CJ, Meyerle C, Sodhi A, Linz MO, Sophie R, Campochiaro PA.

Ophthalmology. 2016 Mar;123(3):625-34.e1. doi: 10.1016/j.ophtha.2015.10.030. Epub 2015 Dec 19.



Chhablani J, Kozak I, Pichi F, Chenworth M, Berrocal MH, Bedi R, Singh RP, Wu L, Meyerle C, Casella AM, Mansour A, Bashshur Z, Scorza A, Carrai P, Nucci P, Arevalo JF; King Khaled Eye Specialist Hospital International Collaborative Retina Study Group.

Retina. 2015 Dec;35(12):2489-97. doi: 10.1097/IAE.0000000000000655.


Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.

Nicholson BP, Nigam D, Toy B, Stetson PF, Agrón E, Jacobs-El N, Cunningham D, Cukras C, Wong W, Wiley H, Chew E, Ferris F, Meyerle CB.

Retina. 2015 Jan;35(1):58-68. doi: 10.1097/IAE.0000000000000260.


In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration.

Chu XK, Meyerle CB, Liang X, Chew EY, Chan CC, Tuo J.

Age (Dordr). 2014 Jun;36(3):9627. doi: 10.1007/s11357-014-9627-2. Epub 2014 Feb 14.


Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration.

Dalal M, Jacobs-El N, Nicholson B, Tuo J, Chew E, Chan CC, Nussenblatt R, Ferris F, Meyerle C.

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2705-9. doi: 10.1007/s00417-013-2375-7. Epub 2013 May 21.


Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Ardeljan D, Meyerle CB, Agron E, Wang JJ, Mitchell P, Chew EY, Zhao J, Maminishkis A, Chan CC, Tuo J.

Eur J Hum Genet. 2013 Oct;21(10):1152-7. doi: 10.1038/ejhg.2013.14. Epub 2013 Feb 20.


Central serous chorioretinopathy: update on pathophysiology and treatment.

Nicholson B, Noble J, Forooghian F, Meyerle C.

Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004. Review.


Hypomethylation of the IL17RC promoter associates with age-related macular degeneration.

Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen HN, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris FL 3rd, Chew EY, McCoy JP, Blum E, Francis PJ, Klein ML, Guymer RH, Baird PN, Chan CC, Nussenblatt RB.

Cell Rep. 2012 Nov 29;2(5):1151-8. doi: 10.1016/j.celrep.2012.10.013. Epub 2012 Nov 21.


Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.

Wang VM, Rosen RB, Meyerle CB, Kurup SK, Ardeljan D, Agron E, Tai K, Pomykala M, Chew EY, Chan CC, Tuo J.

Mol Vis. 2012;18:2578-85. Epub 2012 Oct 20.


Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study.

Cukras CA, Petrou P, Chew EY, Meyerle CB, Wong WT.

Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3865-74. doi: 10.1167/iovs.11-9413.


Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.

Toy BC, Koo E, Cukras C, Meyerle CB, Chew EY, Wong WT.

Retina. 2012 May;32(5):996-1006. doi: 10.1097/IAE.0b013e31824690a8.


Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration.

Liu B, Wei L, Meyerle C, Tuo J, Sen HN, Li Z, Chakrabarty S, Agron E, Chan CC, Klein ML, Chew E, Ferris F, Nussenblatt RB.

J Transl Med. 2011 Jul 15;9:1-12. doi: 10.1186/1479-5876-9-111.


Subconjunctival sirolimus in the treatment of diabetic macular edema.

Krishnadev N, Forooghian F, Cukras C, Wong W, Saligan L, Chew EY, Nussenblatt R, Ferris F 3rd, Meyerle C.

Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1627-33. doi: 10.1007/s00417-011-1694-9. Epub 2011 May 13.


Finasteride for chronic central serous chorioretinopathy.

Forooghian F, Meleth AD, Cukras C, Chew EY, Wong WT, Meyerle CB.

Retina. 2011 Apr;31(4):766-71. doi: 10.1097/IAE.0b013e3181f04a35.


Copy number variations in candidate genes in neovascular age-related macular degeneration.

Liu MM, Agrón E, Chew E, Meyerle C, Ferris FL 3rd, Chan CC, Tuo J.

Invest Ophthalmol Vis Sci. 2011 May 16;52(6):3129-35. doi: 10.1167/iovs.10-6735.


Quantitative assessment of photoreceptor recovery in atypical multiple evanescent white dot syndrome.

Forooghian F, Stetson PF, Gross NE, Meyerle CB.

Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41 Suppl:S77-80. doi: 10.3928/15428877-20101031-06.


A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization.

Nussenblatt RB, Byrnes G, Sen HN, Yeh S, Faia L, Meyerle C, Wroblewski K, Li Z, Liu B, Chew E, Sherry PR, Friedman P, Gill F, Ferris F 3rd.

Retina. 2010 Nov-Dec;30(10):1579-87. doi: 10.1097/IAE.0b013e3181e7978e.


Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Wong WT, Kam W, Cunningham D, Harrington M, Hammel K, Meyerle CB, Cukras C, Chew EY, Sadda SR, Ferris FL.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6131-9. doi: 10.1167/iovs.10-5637. Epub 2010 Jun 23.


Fundus autofluorescence imaging of the white dot syndromes.

Yeh S, Forooghian F, Wong WT, Faia LJ, Cukras C, Lew JC, Wroblewski K, Weichel ED, Meyerle CB, Sen HN, Chew EY, Nussenblatt RB.

Arch Ophthalmol. 2010 Jan;128(1):46-56. doi: 10.1001/archophthalmol.2009.368.


Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Forooghian F, Stetson PF, Meyer SA, Chew EY, Wong WT, Cukras C, Meyerle CB, Ferris FL 3rd.

Retina. 2010 Jan;30(1):63-70. doi: 10.1097/IAE.0b013e3181bd2c5a.


Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis.

Forooghian F, Chew EY, Meyerle CB, Cukras C, Wong WT.

Acta Ophthalmol. 2011 Mar;89(2):e206-7. doi: 10.1111/j.1755-3768.2009.01773.x. No abstract available.


Gallium scintigraphy in the investigation of retinal inflammatory vasculopathy.

Forooghian F, Cukras C, Meyerle CB, Nussenblatt RB, Gottlieb CC, Chew EY, Wong WT.

Acta Ophthalmol. 2010 Nov;88(7):e291-2. doi: 10.1111/j.1755-3768.2009.01725.x. No abstract available.


Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices.

Cukras C, Wang YD, Meyerle CB, Forooghian F, Chew EY, Wong WT.

Eye (Lond). 2010 May;24(5):775-83. doi: 10.1038/eye.2009.211. Epub 2009 Aug 21.


Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration.

Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT.

Retina. 2009 Jun;29(6):723-31. doi: 10.1097/IAE.0b013e3181a2c1c3.


Complementary angiographic and autofluorescence findings in pseudoxanthoma elasticum.

Lee TK, Forooghian F, Cukras C, Wong WT, Chew EY, Meyerle CB.

Int Ophthalmol. 2010 Feb;30(1):77-9. doi: 10.1007/s10792-008-9271-x. Epub 2008 Oct 15.


Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4290-6. doi: 10.1167/iovs.08-2113. Epub 2008 May 30.


Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease.

Meyerle CB, Dahr SS, Wetjen NM, Jirawuthiworavong GV, Butman JA, Lonser RR, Oldfield E, Rodriguez-Coleman H, Wong WT, Chew EY.

Ophthalmology. 2008 Aug;115(8):1382-9. doi: 10.1016/j.ophtha.2008.01.027. Epub 2008 Apr 8.


Acute positive titers of antibody to coxsackievirus in acute idiopathic maculopathy.

Meyerle CB, Yannuzzi LA.

Retin Cases Brief Rep. 2008 Winter;2(1):34-5. doi: 10.1097/01.iae.0000243065.91330.e0.


Autofluorescence of basal laminar drusen.

Meyerle CB, Smith RT, Barbazetto IA, Yannuzzi LA.

Retina. 2007 Oct;27(8):1101-6.


Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy.

Meyerle CB, Freund KB, Bhatnagar P, Shah V, Yannuzzi LA.

Retina. 2007 Sep;27(7):943-6.


Retinal arterial macroaneurysm with blood-staining of the internal limiting membrane and optic nerve.

Meyerle CB, Shields MB, Adelman RA.

Semin Ophthalmol. 2007 Jul-Sep;22(3):185-7.


Fundus autofluorescence in retinopathy caused by deferoxamine toxicity.

Reddy S, Iturralde D, Meyerle C, Gross NE, Yannuzzi LA.

Retin Cases Brief Rep. 2007 Summer;1(3):120-2. doi: 10.1097/01.ICB.0000279640.76453.eb.


Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.

Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM Jr, Fisher YL, Cooney MJ, Yannuzzi LA.

Retina. 2007 Apr-May;27(4):451-7.


Circumferential lacquer cracks in a highly myopic patient.

Meyerle CB, Fernandez CF, Spaide RF.

Retin Cases Brief Rep. 2007 Spring;1(2):57-8. doi: 10.1097/01.ICB.0000264799.25870.bc. No abstract available.


Supplemental Content

Loading ...
Support Center